Trailblazer Sandra Horning Is Helping Companies Break New Ground

Roche’s former chief medical officer has new career as board member to three companies, including COVID-19 vaccine pioneer Moderna, and is co-founder of a startup seeking to develop more affordable drugs. She helped pave the way for FDA’s breakthrough therapy designation and diversification of Genentech’s clinical trials.

Career path
• Source: Alamy

Sandra Horning has played a central role in drug development for more than 30 years, from conducting lymphoma research at Stanford University to overseeing the approval of 15 medicines at Genentech, Inc. She is now tackling some of industry’s most high profile issues, serving as a board member of Moderna, Inc. and advising a start-up seeking to launch new, affordable drugs.

The Healthcare Businesswomen’s Association celebrated Horning’s achievements with its 2020-2021 Women of the Year award, which was presented at a...

More from C-Suite Speaks

More from Leadership